Clinical trial
A Phase III, Randomized Study of Adjuvant Chemotherapy for Patients With Rectal Adenocarcinoma Who Achieved Suboptimal Response After Neoadjuvant Chemo-radiotherapy.
NCT01941979 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Randomized Study of Adjuvant Chemotherapy for Patients With Rectal Adenocarcinoma Who Achieved Suboptimal Response After Neoadjuvant Chemo-radiotherapy.
- Lead sponsor
- Instituto do Cancer do Estado de São Paulo
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 30, 2011
- Completion date
- September 30, 2016
- Enrollment
- 309 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer